Provexis (LON:PXS – Get Free Report) posted its earnings results on Thursday. The company reported GBX (0.02) EPS for the quarter, Digital Look Earnings reports. Provexis had a negative return on equity of 44.78% and a negative net margin of 35.03%.
Provexis Stock Up 2.1%
LON:PXS opened at GBX 0.96 on Friday. Provexis has a twelve month low of GBX 0.55 and a twelve month high of GBX 1.55. The stock has a market cap of £22.52 million, a P/E ratio of -48.00 and a beta of 0.66. The business’s 50-day moving average price is GBX 1.05 and its two-hundred day moving average price is GBX 1.07.
About Provexis
Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function.
Further Reading
- Five stocks we like better than Provexis
- MarketBeat Week in Review – 09/28 – 10/02
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
Receive News & Ratings for Provexis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Provexis and related companies with MarketBeat.com's FREE daily email newsletter.
